Drug Trial Radar · NCT06443944
An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG
Last checked: Nov 20, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Available
Enrollment
Not stated
Start
Not stated
Primary completion
Not stated
Sponsor
- Lead sponsor
- CG Oncology, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 5, 2024
Design
- Study type
- Expanded access
- Who can join
- All sexes, from 18 years
Summary
As written by the sponsor on the registry.
This is an open-label, expanded access trial designed to provide access to cretostimogene in patients with NMIBC (specifically CIS with or without HG Ta/T1) unresponsive to BCG.
Conditions
- Non-Muscle Invasive Bladder Cancer
- Urothelial Carcinoma
- Urologic Cancer
- Bladder Cancer
Interventions
Cretostimogene GrenadenorepvecDrug
Engineered Oncolytic Adenovirus
n-dodecyl-B-D-maltosideOther
Transduction-enhancing agent
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
27 sites in 1 country. Site status is shown where the registry gives one.
Banner MD Anderson Cancer Center
Gilbert, Arizona · Available
Michael G. Oefelein Clinical Trials
Bakersfield, California · Available
University of Southern California / Norris Comprehensive Cancer Center
Los Angeles, California · Available
McR, Llc.
Murrieta, California · Available
MedStar Washington Hospital Center
Washington D.C., District of Columbia · Available
Advanced Urology Institute
Daytona Beach, Florida · Available
Lakeland Regional Medical Center - Hollis Cancer Center
Lakeland, Florida · Available
Advanced Urology Institute
Largo, Florida · Available
Emory University
Atlanta, Georgia · Available
Uropartners c/o Associated Urological Specialists
Chicago Ridge, Illinois · Available
UroPartners, LLC
Glenview, Illinois · Available
Urologic Specialists of Northwest Indiana
Merrillville, Indiana · Available
Urology Center of Iowa Research
Clive, Iowa · Available
Brigham and Women's Hospital
Boston, Massachusetts · Available
Michigan Institute of Urology, PC
Troy, Michigan · Available
Mayo Clinic Rochester
Rochester, Minnesota · Available
The Urology Group, P.C.
Southaven, Mississippi · Available
Urology Nevada
Reno, Nevada · Available
Integrated Medical Professionals, PLLC
New York, New York · Available
MidLantic Urology
Bala-Cynwyd, Pennsylvania · Available
Lowcountry Urology Clinics, PA
North Charleston, South Carolina · Available
Urology Partners of North Texas Research Institute
Arlington, Texas · Available
Urology Clinics of North Texas
Dallas, Texas · Available
Urology San Antonio, PA dba USA Clinical Trials
San Antonio, Texas · Available
Digestive Health Research of North Texas
Wichita Falls, Texas · Available
University of Washington Medical Center
Seattle, Washington · Available
Spokane Urology
Spokane, Washington · Available
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.